Palomino Laboratories (PALX) Return on Equity (2023 - 2025)

Palomino Laboratories has disclosed Return on Equity across 3 years of filings, most recently posting 0.0% for Q4 2025.

• Return on Equity for Q4 2025 came in at 0.0%, down 17.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.0% (down 17.0% YoY), and the FY2024 annual result was 0.08%, up 4.0% from the prior year.
• Return on Equity came in at 0.0% for Q4 2025 at Palomino Laboratories, up from 0.01% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.73% in Q2 2024 to a low of 0.01% in Q3 2025.
• The 3-year median for Return on Equity is 0.01% (2023), against an average of 0.13%.
• Across the five-year window, Return on Equity rose 22 bps in 2024 and plunged 72 bps in 2025, its largest moves.
• Palomino Laboratories' Return on Equity stood at 0.02% in 2023, then jumped by 966 bps to 0.17% in 2024, then slumped by 101 bps to 0.0% in 2025.
• The last three Return on Equity figures came in at 0.0% (Q4 2025), 0.01% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.